Advances in detecting and responding to threats from bioterrorism and emerging infectious disease

Nature Medicine

Volumn 10, Issue 12S, 2004, Pages S130-S136

  Rotz, Lisa D ^a   Hughes, James M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BIOSAFETY; COMMUNITY; DATA ANALYSIS; DIAGNOSTIC VALUE; ENVIRONMENTAL MONITORING; EPIDEMIC; GEOGRAPHIC INFORMATION SYSTEM; GOVERNMENT; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INFECTION; INFECTION CONTROL; INFECTION SENSITIVITY; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL INFORMATION SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

BIOLOGICAL WARFARE; BIOTERRORISM; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DISASTER PLANNING; DISEASE OUTBREAKS; HUMANS; PUBLIC HEALTH;

BACILLUS ANTHRACIS;

EID: 10944245505     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1152     Document Type: Review

References (56)

1. Meltzer, M.I., Damon, I., LeDuc, J.W. & Millar, J.D. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg. Infect. Dis. 7, 959-969 (2001).
2. Klein, R.W., Dittus, R.S., Roberts, S.D. & Wilson, J.R. Simulation modeling and health-care decision mak- ing. Med. Decis. Making 13, 347-354 (1993).
3. Kaufmann, A.F., Meitzer, M.I. & Schmid, G.P. The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? Emerg. infect. Dis. 3, 83-94 (1997).
4. Waiden, J. & Kaplan, E.H. Estimating time and size of bioterror attack. Emerg. infect. Dis. 10, 1202-1205 (2004).
5. Brookmeyer, R., Johnson, E. & Bollinger, R. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc. Natl. Acad. Sci. USA 100, 10129-10132 (2003).
6. Gani, R. & Leach, S. Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerg. infect. Dis. 10, 608-614 (2004).
7. Wein, L.M., Craft, D.L. & Kaplan, E.H. Emergency response to an anthrax attack. Proc. Natl. Acad. Sci. USA 100, 4346-4351 (2003).
8. Community-based mass prophylaxis: A planning guide for public health preparedness (Agency for Healthcare Research and Quality, Rockville, Maryland, USA, 2004). http://www.ahrq.gov/research/cbmprophyl/cbm- pro.htm
9. Andress, K. A postevent smallpox mass vaccination clinic exercise. Disaster Manag. Response 1, 54-58 (2003).
10. O’Toole, T., Mair, M. & Inglesby, T.V. Shining light on “Dark Winter”. Clin. infect. Dis. 34, 972-983 (2002).
11. Buehler, J.W., Berkelman, R.L., Hartley, D.M. & Peters, C.J. Syndromic surveillance and bioterrorism- related epidemics. Emerg. infect. Dis. 9, 1197-1204 (2003).
12. Pavlin, J.A. & Kelley, P.W. ESSENCE: Electronic Surveillance System for the Early Notification of Community-based Epidemics (U. S. Department of Defense, Global Emerging Infections Surveillance and Response System, Silver Spring, Maryland, USA, 2001).
13. Lombardo, J. et al. A systems overview of the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE II). J. Urban Health 80, i32-i42 (2003).
14. Lober, W.B. et al. Syndromic surveillance using automated collection of computerized discharge diagnoses. J. Urban Health80, i97-i106 (2003).
15. Takahashi, H., Fujii, H., Shindo, N. & Taniguchi, K. Evaluation of the Japanese school health surveillance system for influenza. Jpn. J. infect. Dis. 54, 27-30 (2001).
16. Quenel, P. & Dab, W. Influenza A and B epidemic criteria based on time-series analysis of health services surveillance data. Eur. J. Epidemiol. 14, 275-285 (1998).
17. Bravata, D.M. et al. Systematic review: Surveillance systems for early detection of bioterrorism-related diseases. Ann. intern. Med. 140, 910-922 (2004).
18. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems. Recommendations from the Guidelines Working Group. MMWR Recomm. Rep. 50, 1-35 (2001).
19. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks: Recommendations from the CDC Working Group. MMWR Recomm. Rep. 53, 1-11 (2004).
20. Reingold, A. If syndromic surveillance is the answer, what is the question? Biosecur. Bioterror. 1, 77-81 (2003).
21. Centers for Disease Control and Prevention. Syndromic Surveillance: Reports from a National Conference, 2003. MMWR Morb. Mortal. Wkly. Rep. 53 (2004).
22. Mostashari, F., Fine, A., Das, D., Adams, J. & Layton, M. Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City. J. Urban Health 80, i43-i49 (2003).
23. Reis, B.Y. & Mandl, K.D. Syndromic surveillance: The effects of syndrome grouping on model accuracy and outbreak detection. Ann. Emerg. Med. 44, 235-241 (2004).
24. Fleischauer, A.T. & Silk, B.J. The validity of chief complaint and discharge diagnosis in emergency department-based syndromic surveillance. Acad. Emergency Med. (in the press).
25. Centers for Disease Control and Prevention. The state of statistical process control as we proceed into the 21st century. J. Am. Statist. Assoc. 95, 992-998 (2000).
26. Hutwagner, L., Thompson, W., Seeman, G.M. & Treadwell, T. The bioterrorism preparedness and response Early Aberration Reporting System (EARS). J. Urban Health 80, i89-i96 (2003).
27. Das, D. et al. Enhanced drop-in syndromic surveillance in New York City following September 11, 2001. J. Urban Health 80, i76-i88 (2003).
28. Heffernan, R. et al. Syndromic surveillance in public health practice, New York City. Emerg. Infect. Dis. 10, 858-864 (2004).
29. Bravata, D.M. et al. Bioterrorism preparedness and response: Use of information technologies and decision support systems. Evid. Rep. Technol. Assess. 1-8 (2002).
30. Tsui, F.C. et al. Technical description of RODS: A realtime public health surveillance system. J. Am. Med. inform. Assoc. 10, 399-408 (2003).
31. Heymann, D.L. & Rodier, G.R. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet infect. Dis. 1, 345-353 (2001).
32. Heymann, D.L. & Rodier, G. Global surveillance, national surveillance, and SARS. Emerg. infect. Dis. 10, 173-175 (2004).
33. Fitch, J.P. et al. Rapid development of nucleic acid diagnostics. Proc. iEEE90, 1780-1721 (2002).
34. Fitch, J.P., Raber, E. & Imbro, D.R. Technology challenges in responding to biological or chemical attacks in the civilian sector. Science 302, 1350-1354 (2003).
35. Centers for Disease Control and Prevention. Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace. MMWR Recomm. Rep. 53, 1-12 (2004).
36. McBride, M.T. et al. Multiplexed liquid arrays for simultaneous detection of simulants of biological warfare agents. Anal. Chem. 75, 1924-1930 (2003).
37. Houston Department of Health and Human Services & Harris County Public Health and Environmental Services. Officials following up on bacteria detection (press release) October 9 (2004).http://www.ci.hous- ton.tx.us/departme/health/bacteria%20detection.htm
38. Berger, E. Suspicious bacteria detected; Security monitors spot germ; terrorism discounted. The Houston (TX) Chronicle, 10 Oct (2003).
39. Morse, S.A. et al. Detecting biothreat agents: The Laboratory Response Network. ASM News 69, 433-437 (2003).
40. Rotz, L.D., Khan, A.S., Lillibridge, S.R., Ostroff, S.M. & Hughes, J.M. Public health assessment of potential biological terrorism agents. Emerg. infect. Dis. 8, 225-230 (2002).
41. Hoffmaster, A.R. et al. Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg. infect. Dis. 8, 1178-1182 (2002).
42. Golub, T.R. et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science286, 531-537 (1999).
43. Gerhold, D.L., Jensen, R.V. & Gullans, S.R. Better therapeutics through microarrays. Nat. Genet. 32, 547-551 (2002).
44. Langlois, R.G. et al. Development of an autonomous pathogen detection system in the Proceedings of the Joint Conference on Point Detection for Chemical and Biological Defense (Williamsburg, Virginia, 2000).
45. Rao, R.S. et al. Comparison of multiplexed techniques for detection of bacterial and viral proteins. J. Proteome. Res. 3, 736-742 (2004).
46. Zubieta, J.C., Skinner, R. & Dean, A.G. Initiating informatics and GIS support for a field investigation of bioterrorism: The New Jersey anthrax experience. int. J. Health Geogr. 2, 8 (2003).
47. Reissman, D.B., Steinberg, E.B., Magri, J.M. & Jernigan, D.B. The anthrax epidemiologic tool kit: An instrument for public health preparedness. Biosecur. Bioterror. 1, 111-116 (2003).
48. Torok, T.J. et al. A large community outbreak of sal- monellosis caused by intentional contamination of restaurant salad bars. JAMA 278, 389-395 (1997).
49. Steyn, B. in Scientific and Technical Means of Distinguishing Between Natural and Other Outbreaks of Disease (eds. Dando, M., Pearson, G. S. & Kriz, B.) 87-92 (Kluwer Academic Publishers, Dordrecht, The Netherlands, 2001).
50. Noah, D.L., Sobel, A.L., Ostroff, S.M. & Kildew, J.A. Biological warfare training: Infectious disease outbreak differentiation criteria. Mil. Med. 163, 198-201 (1998).
51. Treadwell, T.A., Koo, D., Kuker, K. & Khan, A.S. Epidemiologic clues to bioterrorism. Public Health Rep. 118, 92-98 (2003).
52. LeDuc, J.W., Ostroff, S.M., McDade, J.E., Lillibridge, S. & Hughes, J.M. in Emerging infections (eds. Scheld, W.M., Craig, W.A. & Hughes, J.M.) 219-230 (ASM Press, Washington, DC, 1999).
53. Grunow, R. & Finke, E.J. A procedure for differentiating between the intentional release of biological warfare agents and natural outbreaks of disease: Its use in analyzing the tularemia outbreak in Kosovo in 1999 and 2000. Clin. Microbiol. infect. 8, 510-521 (2002).
54. Bravata, D. M. et al. A conceptual framework for evaluating information technologies and decision support systems for bioterrorism preparedness and response. Med. Decis. Making 24, 192-206 (2004).
55. Schuler, A. Billions for biodefense: Federal agency biodefense funding, FY2001-FY2005. Biosecur. Bioterror. 2, 86-96 (2004).
56. Gilfillan, L. et al. Taking the measure of countermea- sures: Leaders’ views on the nation’s capacity to develop biodefense countermeasures. Biosecur. Bioterror. 2, 1-8 (2004).